For IgM, the analysis estimated a pooled prevalence of 5.9% (95% CI: 0–12.5%), with high heterogeneity (I2 = 88%, p < 0.01), indicating relatively low recent infection rates at the population level. The gene discussed is CD40LG; the disease is infection.